Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MDA-MB-134-VI
HR+
Luminal
Temsirolimus
MTOR
MTOR
10998.144
uM
0.12878
3.20740
-0.9804 -1.0000 0.3417 0.6578
0.8701
0.8153
MDA-MB-134-VI
HR+
Luminal
Temsirolimus
MTOR
MTOR
12206.144
uM
0.03827
8.72280
-0.4314 -1.0000 0.2024 0.6778
0.9122
0.9811
MDA-MB-134-VI
HR+
Luminal
Topotecan
TOP1
TOP
10077.121
uM
0.12958
0.67348
-0.8739 -0.9510 0.6464 0.8008
0.9692
0.4875
MDA-MB-134-VI
HR+
Luminal
Topotecan
TOP1
TOP
7876.007
uM
0.10293
0.75762
-0.4533 -0.6513 0.4178 0.6571
0.9747
1.0246
MDA-MB-134-VI
HR+
Luminal
Topotecan
TOP1
TOP
7877.007
uM
0.00865
0.07627
-0.8458 -0.9029 0.4739 1.0580
0.9853
0.5977
MDA-MB-134-VI
HR+
Luminal
Torkinib
15355.211
uM
0.00026
0.00531
-0.8198 -0.8282 0.3225 1.2019
0.9869
1.0584
MDA-MB-134-VI
HR+
Luminal
Tozasertib
AURK/FLT3/ABL/JAK2
AURK
12206.16
uM
0.59013
9.04520
-0.3449 -1.0000 0.4025 0.3712
0.9459
0.9874
MDA-MB-134-VI
HR+
Luminal
Tozasertib
AURK/FLT3/ABL/JAK2
AURK
10998.15
uM
0.75476
6.05740
-0.0157 -0.5235 0.3440 0.3452
0.9643
0.8386
MDA-MB-134-VI
HR+
Luminal
Tozasertib
AURK/FLT3/ABL/JAK2
AURK
10519.138
uM
1.92620
22.51750
-0.3058 -1.0000 0.4468 0.3797
0.9895
1.0592
MDA-MB-134-VI
HR+
Luminal
TPCA-1
IKK
NFKB
10519.1
uM
28.88770
64.81310
0.1813 -0.3290 0.6257 0.1749
0.9115
1.0071
MDA-MB-134-VI
HR+
Luminal
TPCA-1
IKK
NFKB
10419.093
uM
3.36240
2.69790
0.2245 0.3337 5.0000 0.1866
0.9331
0.5719
MDA-MB-134-VI
HR+
Luminal
Trametinib
MEK
MAPK
7877.05
uM
0.00838
0.01740
-0.5316 -0.5391 1.0002 0.8197
0.9799
0.5502
MDA-MB-134-VI
HR+
Luminal
Trametinib
MEK
MAPK
7876.036
uM
0.02479
0.03181
-0.1368 -0.1023 0.7472 0.5224
0.9899
0.8885
MDA-MB-134-VI
HR+
Luminal
Trastuzumab
HER2
ErbB
10077.026
uM
7.0350
7.93710
0.4622 -0.4084 4.9480 -0.0133
0.9348
0.3999
MDA-MB-134-VI
HR+
Luminal
Trichostatin A
HDAC
HDAC
10419.065
uM
8.59820
11.89210
-0.9567 -0.7424 2.8064 0.8183
0.9774
0.7359
MDA-MB-134-VI
HR+
Luminal
Trichostatin A
HDAC
HDAC
7494.065
uM
3.18730
8.28320
-0.9774 -0.9161 1.0901 0.9686
0.9832
0.6688
MDA-MB-134-VI
HR+
Luminal
Triciribine
AKT
AKT
7494.074
uM
0.43155
0.25258
0.2066 0.1165 0.4950 0.3473
0.9907
0.6767
MDA-MB-134-VI
HR+
Luminal
Valproic acid
HDAC
HDAC
12206.143
uM
507.36750
1000.00000
-0.9356 -0.6985 1.2884 0.3310
0.9404
1.0676
MDA-MB-134-VI
HR+
Luminal
Valproic acid
HDAC
HDAC
10998.143
uM
478.31690
1000.00000
-0.9978 -0.9105 1.4062 0.4483
0.9754
0.5976
MDA-MB-134-VI
HR+
Luminal
Vinorelbine
TUBB
TUBB
7876.042
uM
0.03332
0.03940
-0.9030 -0.3271 3.0038 0.7241
0.8621
1.0958
MDA-MB-134-VI
HR+
Luminal
Vinorelbine
TUBB
TUBB
7877.042
uM
0.00423
0.00521
-0.9988 -0.7895 4.5360 1.2744
0.9640
0.3414
MDA-MB-134-VI
HR+
Luminal
Vorinostat
HDAC
HDAC
10419.065
uM
35.57540
66.01640
-0.7437 -0.6450 1.3401 0.7242
0.9857
0.7359
MDA-MB-134-VI
HR+
Luminal
Vorinostat
HDAC
HDAC
7494.065
uM
33.96610
84.09910
-0.8999 -0.8103 1.0626 0.7825
0.9875
0.6688
MDA-MB-134-VI
HR+
Luminal
XRP44X
ELK3
MAPK
10998.151
uM
0.59196
0.63270
0.0499 -0.0948 2.6094 0.4574
0.9332
0.6986
MDA-MB-134-VI
HR+
Luminal
XRP44X
ELK3
MAPK
12206.157
uM
0.76755
1.04930
-0.3319 -0.3141 1.5590 0.5114
0.9889
0.9766